View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Mads Brinkmann Andersen
  • Mads Brinkmann Andersen

ISS (Buy, TP: DKK171.00) - Potential catalysts undervalued

Heading into next year with several potential catalysts, we find the stock attractively valued at a NTM P/E of 7.8x. We expect ISS to meet consensus for 2025e organic growth largely on pricing alone, and new contract wins to drive revisions throughout the year. With the end in sight for the Deutsche Telekom (DTAG) arbitration case and the new key shareholder’s previous activist tendencies, we like the risk/reward. We reiterate our BUY and DKK171 target price.

ABGSC Strategy Research ... (+2)
  • ABGSC Strategy Research
  • Christer Linde

Nordic shorts: review 2024 & 2025 ideas

Shorts update: Grieg Seafood, Fortnox, Embracer, Valmet and ISS higlighted

 PRESS RELEASE

Changes in company's own shares

Changes in company's own shares Company Announcement Copenhagen, 16 December 2024 No. 63/2024 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Sa...

 PRESS RELEASE

Transactions in connection with share buyback programme

Transactions in connection with share buyback programme Company Announcement Copenhagen, 9 December 2024 No. 62/2024 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, als...

 PRESS RELEASE

Election of group employee representatives to the Board of Directors o...

Election of group employee representatives to the Board of Directors of ISS A/S Company Announcement Copenhagen, 3 December 2024 No. 61/2024 Supplementary election of group employee representative and alternates to the Board of Directors of ISS A/S ISS A/S, a leading workplace experience and facility management company, hereby announces that a supplementary election of a group employee representative to the Board of Directors of ISS A/S has been held with the following elected as a Board member for the remainder of the existing 4-year term (until April 2027): Tove Møller Erikse...

ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Oscar Rönnkvist
  • Simon Jönsson
 PRESS RELEASE

Transactions in connection with share buyback programme

Transactions in connection with share buyback programme Company Announcement Copenhagen, 2 December 2024 No. 60/2024 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, als...

Wedbush Research
  • Wedbush Research
LOGI LOGITECH INTERNATIONAL S.A.
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TOL TOLL BROTHERS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GPRO GOPRO INC. CLASS A
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CRM SALESFORCE.COM INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BBY BEST BUY CO. INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
ISR ISORAY
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
HEAR TURTLE BEACH CORP.
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
CRSR CORSAIR GAMING
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
AVTE AEROVATE THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
ABGSC Seafood Research ... (+3)
  • ABGSC Seafood Research
  • Martin Kaland
  • Simon Brun
Alexander Aukner
  • Alexander Aukner

Grieg Seafood (Buy, TP: NOK71.00) - Canada divestment materialising

Q3 operating EBIT was NOK-175m, above our forecast and consensus of NOK-229m. While the Canada sales/partnership process is dragging out in time, the company still expects this to materialise. Grieg Seafood has signed a bridge loan of NOK750m to boost the financial runway until the process is concluded. We have slightly raised our 2025–2026e EPS on lower Rogaland costs. We reiterate our BUY and NOK71 target price.

ABGSC Seafood Research ... (+3)
  • ABGSC Seafood Research
  • Martin Kaland
  • Simon Brun
 PRESS RELEASE

Transactions in connection with share buyback programme

Transactions in connection with share buyback programme Company Announcement Copenhagen, 25 November 2024 No. 59/2024 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, al...

ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Oscar Rönnkvist
  • Simon Jönsson
ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Oscar Rönnkvist
  • Simon Jönsson
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch